Murine Models of Heme Metabolism and Iron Recycling
血红素代谢和铁回收的小鼠模型
基本信息
- 批准号:8737253
- 负责人:
- 金额:$ 38.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-18 至 2017-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAffinityAnemiaAnemia due to Chronic DisorderAnimalsBiologyBlood VesselsBypassCaenorhabditis elegansCell membraneCellsChronicCloningComplexDataDefectDevelopmentDietDietary IronDiffuseDiseaseEndowmentEnterocytesEpithelial CellsErythrocytesErythroidErythropoiesisGene TargetingGenesGrantHemeHeme IronHemeproteinsHemoglobinHemoglobinopathiesHemolysisHistocompatibility TestingHumanIn VitroInflammationInheritedIntestinesIronIron OverloadIron deficiency anemiaMammalian CellMammalsMetabolismModelingMolecularMolecular GeneticsMusNutritionalOrthologous GeneOxygenPathogenesisPathway interactionsPatternPhagocytosisPhenotypePhysiologicalPlayProteinsRecyclingRegulationReticuloendothelial SystemRoleSourceStressTechnologyTestingThalassemiaTissuesTranslatingValidationWhole Organismabsorptionagedbasecell typecommon treatmentembryonic stem cellheme 1heme aheme biosynthesisin vivoinsightiron deficiencyiron metabolismmacrophagemutantpublic health relevanceresearch studyresponsetooltransmission process
项目摘要
DESCRIPTION (provided by applicant): Nearly two-thirds of the body's iron endowment is in the form of hemoglobin and each red blood cell contains more than a billion iron atoms in the form of heme. Consequently, it is not surprising that inherited or acquired defects in hemoglobin synthesis, including the thalassemias, hemoglobinopathies, iron deficiency, and the anemia of inflammation are among the most prevalent human afflictions. Importantly, most of the ~25 mg of iron required to synthesize the hemoglobin in ~360 billion RBCs each day (5 million/sec) derives from recycling of heme-iron from aged RBCs catabolized by reticuloendothelial system (RES) macrophages; at steady state, dietary heme and non-heme iron absorption contribute only 1-2 mg/day to the systemic iron economy, and up to two-thirds of this is absorbed as heme-iron. Nevertheless, despite the importance of RES iron recycling and intestinal heme absorption, the molecular pathways of transmembrane heme transport in macrophages and intestinal epithelial cells have, for the most part, remained unknown. This is in large part due to technical difficulties in identifying heme-specific transporters in mammalian cells and the inability to translate these finding to whole organisms. Recently, using C. elegans, which bypasses several of the technical hurdles presented by mammalian cells, our collaborators identified a protein, heme-responsive gene 1 (hrg-1), which functions a heme transporter. Our preliminary in vitro and in vivo data strongly suggest that the mammalian ortholog of hrg-1, HRG1, is involved in macrophage iron recycling, intestinal heme absorption, as well as intraerythroid and hepatocellular heme metabolism. Here, we propose to investigate the in vivo function of Hrg1 in the mouse by examining its regulation in macrophages and intestinal epithelial cells in response to heme and iron, as phagocytosed red blood cells, as well inflammation, all of which modulate systemic iron metabolism and contribute to the pathogenesis of common nutritional, acquired, and inherited anemias. In addition, we will directly test the hypothesis that Hrg1 is essential for
macrophage iron recycling, intestinal heme absorption, and intraerythroid iron metabolism using conditional gene targeting technology in the mouse. We expect that the collective results will yield substantial insight into these hitherto obscure aspects of heme and iron biology that are critical to our understanding and rational treatment of these common diseases.
描述(由申请人提供):人体近三分之二的铁元素以血红蛋白的形式存在,每个红细胞含有超过十亿以血红素形式存在的铁原子。因此,血红蛋白合成的遗传性或获得性缺陷,包括地中海贫血、血红蛋白病、缺铁和炎症性贫血是人类最普遍的疾病之一,也就不足为奇了。重要的是,每天约 3600 亿个红细胞(500 万个/秒)合成血红蛋白所需的约 25 毫克铁,大部分来自网状内皮系统 (RES) 巨噬细胞分解代谢的老化红细胞中血红素铁的回收;在稳定状态下,膳食血红素和非血红素铁的吸收仅对全身铁经济贡献 1-2 毫克/天,其中多达三分之二以血红素铁的形式被吸收。然而,尽管RES铁回收和肠道血红素吸收很重要,但巨噬细胞和肠上皮细胞中跨膜血红素转运的分子途径在很大程度上仍然未知。这在很大程度上是由于在哺乳动物细胞中鉴定血红素特异性转运蛋白的技术困难以及无法将这些发现转化为整个生物体。最近,我们的合作者利用秀丽隐杆线虫绕过了哺乳动物细胞所面临的几个技术障碍,鉴定出了一种蛋白质,即血红素反应基因 1 (hrg-1),它具有血红素转运蛋白的功能。我们的初步体外和体内数据强烈表明,hrg-1 的哺乳动物直系同源物 HRG1 参与巨噬细胞铁回收、肠道血红素吸收以及红细胞内和肝细胞血红素代谢。在这里,我们建议通过检查 Hrg1 在巨噬细胞和肠上皮细胞中对血红素和铁的反应(如吞噬红细胞)以及炎症的调节来研究 Hrg1 在小鼠体内的功能,所有这些都调节全身铁代谢和导致常见营养性贫血、获得性贫血和遗传性贫血的发病机制。此外,我们将直接检验 Hrg1 对于
使用条件基因靶向技术在小鼠中进行巨噬细胞铁回收、肠道血红素吸收和红细胞内铁代谢。我们期望集体结果将对血红素和铁生物学的这些迄今为止模糊的方面产生实质性的见解,这对于我们理解和合理治疗这些常见疾病至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK D FLEMING其他文献
MARK D FLEMING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK D FLEMING', 18)}}的其他基金
Erythrocyte maturation through global remodeling of the proteome
通过蛋白质组的整体重塑实现红细胞成熟
- 批准号:
10378459 - 财政年份:2021
- 资助金额:
$ 38.26万 - 项目类别:
Erythrocyte maturation through global remodeling of the proteome
通过蛋白质组的整体重塑实现红细胞成熟
- 批准号:
10211683 - 财政年份:2021
- 资助金额:
$ 38.26万 - 项目类别:
Erythrocyte maturation through global remodeling of the proteome
通过蛋白质组的整体重塑实现红细胞成熟
- 批准号:
10598561 - 财政年份:2021
- 资助金额:
$ 38.26万 - 项目类别:
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine
骨髓衰竭和 MDS 的系统生物学用于精准医学
- 批准号:
10018490 - 财政年份:2019
- 资助金额:
$ 38.26万 - 项目类别:
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine
骨髓衰竭和 MDS 的系统生物学用于精准医学
- 批准号:
10228701 - 财政年份:2019
- 资助金额:
$ 38.26万 - 项目类别:
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine
骨髓衰竭和 MDS 的系统生物学用于精准医学
- 批准号:
10454344 - 财政年份:2019
- 资助金额:
$ 38.26万 - 项目类别:
Systems Biology of Bone Marrow Failure and MDS for Precision Medicine
骨髓衰竭和 MDS 的系统生物学用于精准医学
- 批准号:
10669683 - 财政年份:2019
- 资助金额:
$ 38.26万 - 项目类别:
A novel program of ubiquitination in global remodeling of the erythroid proteome
红系蛋白质组全局重塑中的泛素化新程序
- 批准号:
8886115 - 财政年份:2015
- 资助金额:
$ 38.26万 - 项目类别:
Murine Models of Heme Metabolism and Iron Recycling
血红素代谢和铁回收的小鼠模型
- 批准号:
8615014 - 财政年份:2013
- 资助金额:
$ 38.26万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向免疫疗法标志物识别的基于多特征融合的肽与MHC亲和力预测研究
- 批准号:62302277
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
DNA四面体限域辅助的高亲和力铅笔芯微电极用于早期癌症精准诊断研究
- 批准号:22304062
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
相似海外基金
The non-catalytic function of PARP2 in DNA repair and cancer therapy
PARP2在DNA修复和癌症治疗中的非催化功能
- 批准号:
10641934 - 财政年份:2022
- 资助金额:
$ 38.26万 - 项目类别:
Novel Point-of-Care Device for Urinary Hepcidin to Detect Iron Deficiency in Children and Adolescents
用于检测儿童和青少年缺铁情况的新型尿铁调素护理点设备
- 批准号:
10597914 - 财政年份:2022
- 资助金额:
$ 38.26万 - 项目类别:
The non-catalytic function of PARP2 in DNA repair and cancer therapy
PARP2在DNA修复和癌症治疗中的非催化功能
- 批准号:
10540084 - 财政年份:2022
- 资助金额:
$ 38.26万 - 项目类别:
Novel Point-of-Care Device for Urinary Hepcidin to Detect Iron Deficiency in Children and Adolescents
用于检测儿童和青少年缺铁情况的新型尿铁调素护理点设备
- 批准号:
10709598 - 财政年份:2022
- 资助金额:
$ 38.26万 - 项目类别:
Base editing and prime editing for sickle cell disease
镰状细胞病的碱基编辑和引物编辑
- 批准号:
10579903 - 财政年份:2021
- 资助金额:
$ 38.26万 - 项目类别: